Europe's health & life sciences magazine launching on 12 October 2026. Four issues a year, in print. For innovators, health systems, policymakers, healthcare professionals, investors, patient organisations, and more.
Issue 01 - Counting on Europe - Autumn 2026 now available!
Reporting on health and life sciences in Europe for Rapporteur (Euractiv), EU Perspectives, European Biotechnology Magazine and APM Market Access.
Commissioned writing and editing for organisations in health and life sciences. Interviews, features, reports, and the editing that makes them shine.
EU PERSPECTIVES - As US drug pricing policy raises concerns over Europe's access to new medicines, lawmakers are urging member states to pool their bargaining power. The biotech industry, however, sees the pressure from Washington as a short-term shock and wants Europe to focus on its own competitiveness. Read more
EU PERSPECTIVES - A new medicine could reach the market the day it wins EU approval, yet stay out of reach for most patients. For Valentina Strammiello of the European Patients' Forum,that would only deepen inequality. And governments, she says, are waking up late. Read more
RAPPORTEUR (EURACTIV) - Dependence on China, trade frictions with the US and job cuts at GSK in Belgium are "coming all at once", an adviser to Belgium's health minister said on Wednesday. Read more
RAPPORTEUR (EURACTIV) - Belgium wants health and biotech split off from agriculture and bioeconomy in the European Competitiveness Fund, the cabinet of health minister Frank Vandenbroucke told Rapporteur. Read more
